A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, ...

Nat Clin Pract Endocrinol Metab. 2008;4(5):242-243. The thyroid gland is a frequent site of abnormal epithelial cell proliferation. Proliferative diseases of the thyroid follicular cells that arise as ...

Statins, first developed as lipid-lowering agents, have emerged as promising adjuncts in the management of gynecological malignancies, particularly ovarian cancer. By inhibiting HMG-CoA reductase, ...

Cholesterol-related heart disease remains the leading cause of death worldwide, and while doctors have more tools than ever ...

Cholesterol-related heart disease remains the leading cause of death worldwide. The post Scientists find alternative drug to ...

Some types of cancer have a relentless appetite for the metabolite cholesterol, using as much as they can access to accelerate their growth beyond the capabilities of normal cells. Research by ...

Heart disease is still the leading cause of death worldwide, and high cholesterol is a major driver of that problem.

Few medicines have sparked as much debate as statins. Cardiologists often describe them as life-saving, while some patients remain wary of side effects or uneasy about taking a daily pill. Statins sit ...

Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile ...

Munich, Germany - Another study has suggested that there is no interaction between statins and clopidogrel, at least when clopidogrel is administered at a high loading dose of 600 mg. There have been ...

Scientists uncover a hidden liver pathway that destroys LDL receptors, opening a promising new front in the fight against ...